The customer reported a false negative architect total b-hcg on a (b)(6) yr old female patient.Results provided: (b)(6) 2020 (b)(6) = 1.93 iu/l.Patient redrawn on (b)(6) 2020 at another laboratory on dxi800 platform = 1531874 miu/ml, other results provided: progesterone = 45.24 nmol/l, ultrasound estimate( b)(6) pregnant.The patient was administered raceanisodamine hydrochloride intramuscular injection (1ml/10 mg) on (b)(6) 2020 following the negative b-hcg result.The patient self-administered a gi tract medicine (type unknown) on (b)(6) 2020.
|
H6.Health effect impact code: f13.Component code: g01003.D8.Was this device service by a third party? no.The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labelling review, device history record review, and field data review.Trending review determined no trends for the product.Device history record review did not identify any non-conformances or deviations with the likely cause lot.In house testing of the reagent lot was not able to be carried out as the lot 10179ui01 had expired.The overall performance of architect total b-hcg reagents in the field was reviewed using data gathered via abbottlink from customers worldwide and suggested that the performance of the lot is acceptable.Return testing was not completed as returns were not available.A review of the product labeling concluded that the issue is sufficiently addressed.Based on our investigation, we have determined that there is no product deficiency with architect total b-hcg reagent lot 10179ui01.
|